The leaders of MedPath didn’t typically shed tears in their weekly meetings, but this was an exception. Gil Lehner, one of the start-up’s four founders, had just told the others about his diagnosis: He had small cell lung cancer, and while he planned to fight it with his trademark tenacity, his chance of surviving longer than five years was only about 18%.
Read more on Career planning or related topic Work-life balance